229 related articles for article (PubMed ID: 23521319)
1. Down expression of LRP1B promotes cell migration via RhoA/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer.
Ni S; Hu J; Duan Y; Shi S; Li R; Wu H; Qu Y; Li Y
Cancer Sci; 2013 Jul; 104(7):817-25. PubMed ID: 23521319
[TBL] [Abstract][Full Text] [Related]
2. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.
Sonoda I; Imoto I; Inoue J; Shibata T; Shimada Y; Chin K; Imamura M; Amagasa T; Gray JW; Hirohashi S; Inazawa J
Cancer Res; 2004 Jun; 64(11):3741-7. PubMed ID: 15172977
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Csk-binding protein contributes to renal cell carcinogenesis.
Feng X; Lu X; Man X; Zhou W; Jiang LQ; Knyazev P; Lei L; Huang Q; Ullrich A; Zhang Z; Chen Z
Oncogene; 2009 Sep; 28(37):3320-31. PubMed ID: 19581936
[TBL] [Abstract][Full Text] [Related]
5. The tumor-suppressive function of UNC5D and its repressed expression in renal cell carcinoma.
Lu D; Dong D; Zhou Y; Lu M; Pang XW; Li Y; Tian XJ; Zhang Y; Zhang J
Clin Cancer Res; 2013 Jun; 19(11):2883-92. PubMed ID: 23589179
[TBL] [Abstract][Full Text] [Related]
6. Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance.
Yang SF; Hsu HL; Chao TK; Hsiao CJ; Lin YF; Cheng CW
Urol Oncol; 2015 Jan; 33(1):22.e11-22.e21. PubMed ID: 25284003
[TBL] [Abstract][Full Text] [Related]
7. Snail regulates the motility of oral cancer cells via RhoA/Cdc42/p-ERM pathway.
Li YY; Zhou CX; Gao Y
Biochem Biophys Res Commun; 2014 Sep; 452(3):490-6. PubMed ID: 25172658
[TBL] [Abstract][Full Text] [Related]
8. OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma.
Zhang Y; Yuan Y; Liang P; Guo X; Ying Y; Shu XS; Gao M; Cheng Y
Oncotarget; 2017 May; 8(18):30008-30018. PubMed ID: 28404905
[TBL] [Abstract][Full Text] [Related]
9. Hhex inhibits cell migration via regulating RHOA/CDC42-CFL1 axis in human lung cancer cells.
Li X; Ma G; Guo W; Mu N; Wang Y; Liu X; Su L
Cell Commun Signal; 2021 Jul; 19(1):80. PubMed ID: 34321041
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals.
Wang K; Sun Y; Tao W; Fei X; Chang C
Cancer Lett; 2017 May; 394():1-12. PubMed ID: 28089832
[TBL] [Abstract][Full Text] [Related]
12. Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation.
Miranda-Gonçalves V; Lameirinhas A; Macedo-Silva C; Lobo J; C Dias P; Ferreira V; Henrique R; Jerónimo C
Cells; 2020 Apr; 9(4):. PubMed ID: 32340156
[TBL] [Abstract][Full Text] [Related]
13. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
[TBL] [Abstract][Full Text] [Related]
14. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
17. The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.
Sharma A; Mendonca J; Ying J; Kim HS; Verdone JE; Zarif JC; Carducci M; Hammers H; Pienta KJ; Kachhap S
Mol Oncol; 2017 Jun; 11(6):655-669. PubMed ID: 28371345
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of microtubule-associated protein 1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton.
Tang Z; Zhang N; Di W; Li W
Oncol Rep; 2015 Mar; 33(3):1411-7. PubMed ID: 25607473
[TBL] [Abstract][Full Text] [Related]
19. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
[TBL] [Abstract][Full Text] [Related]
20. SPARC mediates Src-induced disruption of actin cytoskeleton via inactivation of small GTPases Rho-Rac-Cdc42.
Bhoopathi P; Gondi CS; Gujrati M; Dinh DH; Lakka SS
Cell Signal; 2011 Dec; 23(12):1978-87. PubMed ID: 21798346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
